Only an overall 15% net benefit emerges in favour of adjuvant intravesical chemotherapy when compared to transurethral resection alone for the prevention of recurrences of superficial bladder tumors.
Posted by Uroexpert | Posted on Saturday, June 5, 2010
Category : adjuvant, alone, benefit, bladder, chemotherapy, compared, emerges, favour, Intravesical, overall, prevention, recurrences, resection, superficial, transurethral, tumors.
0 comments: